<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ICT</journal-id>
<journal-id journal-id-type="hwp">spict</journal-id>
<journal-id journal-id-type="nlm-ta">Integr Cancer Ther</journal-id>
<journal-title>Integrative Cancer Therapies</journal-title>
<issn pub-type="ppub">1534-7354</issn>
<issn pub-type="epub">1552-695X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1534735411399900</article-id>
<article-id pub-id-type="publisher-id">10.1177_1534735411399900</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Co-Inhibition of HSP70/HSP90 Synergistically Sensitizes Nasopharyngeal Carcinoma Cells to Thermotherapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cui</surname><given-names>Xiao-bo</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname><given-names>Zhao-yan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Wei</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zheng</surname><given-names>Yan-qiu</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Wei</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Ling-xiang</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1534735411399900">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1534735411399900"><label>1</label>Inner Mongolia Medical College Hospital, Hohhot, Inner Mongolia, People’s Republic of China</aff>
<author-notes>
<corresp id="corresp1-1534735411399900">Xiaobo Cui, MD, Section of Inner Mongolia Medical College Hospital Otorhinolaryngology, No. 1, Tongdao North Street, Hohhot, 010000 Inner Mongolia, People’s Republic of China Email: <email>cxbgh@sina.com.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<fpage>61</fpage>
<lpage>67</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The upregulation of both HSP70 and HSP90 frequently compromises the effects of thermotherapy. The co-inhibition of HSP70/HSP90 may be preferable to enhance the effects of thermotherapy on nasopharyngeal carcinoma cells. The changes of HSP70 and HSP90 were detected after thermotherapy in human nasopharyngeal cancer cell HNE1. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) and quercetin were used to inhibit the activity of HSP90 and HSP70. The enhanced effects were evaluated in vitro and in vivo. Both HSP70 and HSP90 were upregulated promptly in HNE1 after thermotherapy. Single inhibition of HSP70 resulted in overexpression and delayed descent of HSP90. The co-inhibition of HSP70/HSP90 with quercetin plus 17-DMAG significantly increased apoptosis in hyperthermia-treated HNE1 cells both in vitro and in vivo. The co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to hyperthermia.</p>
</abstract>
<kwd-group>
<kwd>HSP90</kwd>
<kwd>HSP70</kwd>
<kwd>17-DMAG</kwd>
<kwd>quercetin</kwd>
<kwd>thermotherapy</kwd>
<kwd>nasopharyngeal carcinoma</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1534735411399900" sec-type="intro">
<title>Introduction</title>
<p>Thermotherapy has proven an effective approach in cancer therapy. The temperatures used in heat treatments are in the range of 40°C to 45°C in the case of locoregional treatment and up to 42°C in the case of whole body hyperthermia. However, hyperthermia exposure induces synthesis and overexpression of heat shock proteins (HSPs). HSPs behave as molecular chaperones, which act as the primary cellular defense against damage to the proteome, initiating refolding of denatured proteins and regulating degradation after severe protein damage.<sup><xref ref-type="bibr" rid="bibr1-1534735411399900">1</xref></sup> HSPs protect cells both by limiting the effects of protein-damaging agents through protein chaperoning and refolding and by directly blocking the cell-death pathways.<sup><xref ref-type="bibr" rid="bibr2-1534735411399900">2</xref>-<xref ref-type="bibr" rid="bibr5-1534735411399900">5</xref></sup></p>
<p>HSP expression is tightly controlled in normal human cells, whereas it is often dysregulated in tumor cells. Aberrant expression of HSP90, HSP70, HSP27, and HSP40 either individually or in combination has been widely reported in human malignant tumors of various origins.<sup><xref ref-type="bibr" rid="bibr6-1534735411399900">6</xref>-<xref ref-type="bibr" rid="bibr11-1534735411399900">11</xref></sup> More important, these HSPs are inducible to a variety of stresses, especially hyperthermia exposure. Among the HSPs, HSP70 and HSP90 play more important roles and have been linked to cancer resistance to stress-mediated apoptotic signals.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref>,<xref ref-type="bibr" rid="bibr12-1534735411399900">12</xref>-<xref ref-type="bibr" rid="bibr14-1534735411399900">14</xref></sup> The upregulation of HSPs frequently compromises the effects of thermotherapy, although targeting HSPs has proven to be an effective strategy to reverse the thermotolerance of cancer cells.<sup><xref ref-type="bibr" rid="bibr13-1534735411399900">13</xref>,<xref ref-type="bibr" rid="bibr15-1534735411399900">15</xref>,<xref ref-type="bibr" rid="bibr16-1534735411399900">16</xref></sup> However, the single inhibition of HSP90 may induce the upregulation of HSP70 and the induction of HSP70 may ultimately limit the efficacy of HSP90 inhibitors under certain circumstances.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref></sup> Likewise, it can be speculated that the single inhibition of HSP70 may affect the changes of HSP90 in cancer thermotherapy. Therefore, co-inhibition of HSP70/HSP90 may be necessary for better inhibitory efficacy in this situation.</p>
<p>Nasopharyngeal carcinoma (NPC) is one of the most common cancers among Chinese or Asian ancestry. High-dose radiotherapy with adjunctive chemotherapy is the primary treatment of NPC,<sup><xref ref-type="bibr" rid="bibr17-1534735411399900">17</xref></sup> whereas hyperthermia can be an additive strategy as a sensitizer to improve the potential of the radiotherapy or chemotherapy.<sup><xref ref-type="bibr" rid="bibr18-1534735411399900">18</xref>-<xref ref-type="bibr" rid="bibr20-1534735411399900">20</xref></sup> Here, we investigated the changes of the levels of HSP70 and HSP90 and the effects followed by HSP90 or HSP70 inhibition with 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), an HSP90 inhibitor, and quercetin, an HSP70 inhibitor, on NPC cell line HNE1 in response to hyperthermia both in vitro and in vivo.</p>
</sec>
<sec id="section2-1534735411399900" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1534735411399900">
<title>Cell Line and Culture</title>
<p>The human NPC cell line HNE1 (purchased from ATCC) was maintained in Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Invitrogen, Carlsbad, CA) and antibiotics. The culture was maintained in 95% air-humidified atmosphere containing 5% CO<sub>2</sub> at 37°C.</p>
</sec>
<sec id="section4-1534735411399900">
<title>Hyperthermia Treatment</title>
<p>HNE1 cells (2 × 10<sup>5</sup>) were seeded in RPMI-1640 supplemented with 5% FBS in 6-well plates for 24 hours. The cells were pretreated for 10 minutes at increasing temperatures (38°C, 40°C, 41°C, 42°C) and then exposed to heat by placing the cell culture plates into a 42°C, 5% CO<sub>2</sub> incubator for 2 hours. For pretreatment of 17-DMAG and quercetin, the agents were added into the culture media 1 hour before the heat treatment at a final concentration of 17-DMAG (10 µmol) and quercetin (100 µmol). After hyperthermia, the culture media were replaced by DMEM supplemented with 10% FBS. The treated cells were incubated at 37°C for further experiments. Cells were harvested at various times to detect the level of HSP70/HSP90.</p>
</sec>
<sec id="section5-1534735411399900">
<title>Detection of HSP70/HSP90 by Real-Time Polymerase Chain Reaction</title>
<p>Total RNA was extracted with TRI reagent according to the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO). The amount and quality of RNA were quantified by measurement of absorbance at 260 and 280 nm in a UV spectrophotometer. Reverse transcription was carried out using 500 ng of total RNA treated with RT-PCR kit (Takara Bio Inc., Shiga, Japan). The resulting polymerase chain reaction (PCR) products were used to perform real-time PCR. The sequences of the forward and reverse primers for HSP70 and HSP90 mRNA quantification were designed and synthesized by Takara (<xref ref-type="table" rid="table1-1534735411399900">Table 1</xref>). Real-time PCR was performed with ABI PRISM 7000. All measurements were carried out in triplicate. Controls of no template cDNA were included in the PCR experiments. The melting curve was used to check if the amplification products had the expected melting temperature. The mRNA encoding glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a reference to normalize the mRNA of HSPs. The expression levels of HSP70 and HSP90 were quantified as the ratios between their mRNA levels and GAPDH mRNA. We checked that the GAPDH variation coefficient Ct was below 10%. This variation is very low compared with the differential Ct between target mRNA and reference mRNA. Consequently, we can exclude the possibility that the observed variation pattern in HSP expression is because of the variation of the reference GAPDH mRNA itself.</p>
<table-wrap id="table1-1534735411399900" position="float">
<label>Table 1.</label>
<caption>
<p>Real-time PCR Primers</p>
</caption>
<graphic alternate-form-of="table1-1534735411399900" xlink:href="10.1177_1534735411399900-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene</th>
<th align="center">Primers</th>
<th align="center">Sequences</th>
</tr>
</thead>
<tbody>
<tr>
<td>HSP70</td>
<td>TaqMan sequence</td>
<td>5′-ACCTGCTGCTGCTGGACGTGGCGC-3′</td>
</tr>
<tr>
<td/>
<td>Sense primer</td>
<td>5′-GACAAGTCGGAGAACGTGCAG-3′</td>
</tr>
<tr>
<td/>
<td>Antisense primer</td>
<td>5′-TTCACCACCTACTCGGACAACC-3′</td>
</tr>
<tr>
<td>HSP90</td>
<td>TaqMan sequence</td>
<td>5′-AGCAACCTGGTCCTTGGTCTCACCTGT-3′</td>
</tr>
<tr>
<td/>
<td>Sense primer</td>
<td>5′-TTAAGGTACTACACATCTGCCTCT-3′</td>
</tr>
<tr>
<td/>
<td>Antisense primer</td>
<td>5′-TGCTTTCGGAGACGTTCCACAA-3′</td>
</tr>
<tr>
<td>GAPDH</td>
<td>TaqMan sequence</td>
<td>5′-CAAGCTTCCCGTTCTCAGCC-3′</td>
</tr>
<tr>
<td/>
<td>Sense primer</td>
<td>5′-GAAGGTGAAGGTCGGAGTC-3′</td>
</tr>
<tr>
<td/>
<td>Antisense primer</td>
<td>5′-GAAGATGGTGATGGGATTTC-3′</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1534735411399900">
<p>Abbreviations: PCR, polymerase chain reaction; HSP, heat shock protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-1534735411399900">
<title>Western Blot</title>
<p>HNE1 cells were harvested via trypsinization and washed in cold phosphate-buffered saline at 0, 2, 4, 8, 12, and 24 hours after hyperthermia; total cellular protein was extracted. Protein concentration was measured by the Bradford Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s instruction. The antibodies anti-HSP70 and anti-HSP90 (Santa Cruz Biotechnologies, Santa Cruz, CA) were used to determine the expression of HSP70/HSP90. The 2 antibodies were diluted at 1:1 000. The transferred polyvinylidene fluoride membranes were incubated at 4°C for 12 hours. The protein bands were visualized using an enhanced chemiluminescence detection system (Pierce, Rockford, IL).</p>
</sec>
<sec id="section7-1534735411399900">
<title>Flow Cytometry Assay</title>
<p>HNE1 cells, including both attached cells and floating cells, were harvested 24 hours after hyperthermia. Flow cytometric analysis was performed to identify sub-G1 cells/apoptosis cells. Briefly, cells were suspended in 1 mL hypotonic fluorochrome solution containing 50 µg/mL propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100 and were analyzed by a flow cytometer. Apoptosis cells appeared in the cell cycle distribution as cells with DNA content less than that of G1 cells.</p>
</sec>
<sec id="section8-1534735411399900">
<title>Hyperthermia of Established HNE1 Tumor Models</title>
<p>Exponential growth phase HNE1 cells (5 × 10<sup>6</sup>) were subcutaneously inoculated into the right legs of nude mice (6-8 weeks, female). Treatment was started when the volume of the tumor reached 50 mm<sup>3</sup>. Mice were grouped into 6 groups (n = 4) randomly as follows: untreated, hyperthermia, 17-DMAG plus hyperthermia, quercetin plus hyperthermia, 17-DMAG plus quercetin, and 17-DMAG plus quercetin together with hyperthermia. The 17-DMAG (15 mg/kg) and quercetin (5 mg/kg) were administered as described previously,<sup><xref ref-type="bibr" rid="bibr21-1534735411399900">21</xref>,<xref ref-type="bibr" rid="bibr22-1534735411399900">22</xref></sup> and the protocol was adjusted to combine with thermotherapy. The 17-DMAG (intravenous) and quercetin (intraperitoneal) were given once a day for 6 days on days 1 to 6. For better heat response in vivo, the heat treatments with 43°C for 2 hours were performed 2 hours after administration. The mice were then fixed. Heat treatments were performed through dipping the tumor-loading legs into preheated water. All mice were treated twice on days 2 and 5 in a week and then sacrificed. Tumors were harvested, weighed, and fixed with formalin for further experiments.</p>
</sec>
<sec id="section9-1534735411399900">
<title>TUNEL Assay</title>
<p>Tumor tissues were removed from tumor-bearing nude mice 48 hours after the heat treatment. Then cellular apoptosis analysis was performed using a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay according to the manufacturer’s instructions (Roche Diagnostics, Indianapolis, IN).</p>
</sec>
</sec>
<sec id="section10-1534735411399900" sec-type="results">
<title>Results</title>
<sec id="section11-1534735411399900">
<title>Increased Expression of HSP70 and HSP90</title>
<p>We first investigated the expression of HSP70 and HSP90 following hyperthermia. The real-time PCR showed that the expression of both HSP70 and HSP90 upregulated quickly and reached a peak 4 hours after heat treatment. Then, the levels of HSP70 and HSP90 descended and reached the normal level at 24 hours (<xref ref-type="fig" rid="fig1-1534735411399900">Figure 1A</xref>). Similar results were observed for protein expression of HSP70 and HSP90 (<xref ref-type="fig" rid="fig1-1534735411399900">Figure 1B</xref>). The prompt upregulation of HSPs suggests that inhibitors targeting HSPs should be administered before or at an early stage of heat treatment. In this study, HNE1 cells were pretreated with the inhibitors 17-DMAG and quercetin before heat treatment in the following experiments.</p>
<fig id="fig1-1534735411399900" position="float">
<label>Figure 1.</label>
<caption>
<p>HSP70/HSP90 expression in HNE1 cells in response to thermotherapy</p>
<p>A, Real-time polymerase chain reaction analysis of upregulated HSP70/HSP90 gene in HNE1 cells in response to thermotherapy. *<italic>P</italic> &lt; .05. B, HSP70/HSP90 protein expression in HNE1 cells in response to thermotherapy.</p>
</caption>
<graphic xlink:href="10.1177_1534735411399900-fig1.tif"/>
</fig>
</sec>
<sec id="section12-1534735411399900">
<title>Inhibition of HSP70 Results in Prolonged Upregulation of HSP90</title>
<p>A previous report has shown that single inhibition of HSP90 induces the upregulation of HSP70.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref></sup> In this study, we investigated whether single inhibition of HSP70 also induced the upregulation of HSP90. Unexpectedly, the results of real-time PCR revealed that the level of HSP90 did not significantly increase in spite of the inhibition of HSP70. However, a prolonged upregulation of HSP90 was observed both in mRNA and protein levels (<xref ref-type="fig" rid="fig2-1534735411399900">Figures 2A</xref> and <xref ref-type="fig" rid="fig2-1534735411399900">2B</xref>). Therefore, we speculated that co-inhibition of HSP70/HSP90 may promote better effects of thermotherapy in NPC.</p>
<fig id="fig2-1534735411399900" position="float">
<label>Figure 2.</label>
<caption>
<p>Inhibition of HSP70 results in mild upregulation and delayed descent of HSP90 after thermotherapy (*<italic>P</italic> &lt; .05)</p>
<p>A, Changes of HSP70/HSP90 at mRNA level via real-time polymerase chain reaction. HSP90′ represents the changes of HSP90 following hyperthermia without the inhibition of HSP70, whereas HSP90 represents the changes of HSP90 following hyperthermia with the inhibition of HSP70. B, Changes at protein level.</p>
</caption>
<graphic xlink:href="10.1177_1534735411399900-fig2.tif"/>
</fig>
</sec>
<sec id="section13-1534735411399900">
<title>Co-Inhibition of HSP70/HSP90 Sensitizes HNE1 Cells to Hyperthermia Both In Vitro and In Vivo</title>
<p>There are some inhibitors that have demonstrated preclinical efficacy in mouse xenograft models and even in clinical trials.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref>,<xref ref-type="bibr" rid="bibr23-1534735411399900">23</xref>,<xref ref-type="bibr" rid="bibr24-1534735411399900">24</xref></sup> The compound 17-DMAG is an HSP90 inhibitor that is derived from the prototypical ansamycin natural product HSP90 inhibitor geldanamycin, and now undergoing clinical trials.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref>,<xref ref-type="bibr" rid="bibr16-1534735411399900">16</xref></sup> Another natural product, quercetin, is an HSP70 inhibitor that has been reported as a hyperthermia sensitizer by inhibiting the synthesis of HSP70 in a variety of tumor cell lines.<sup><xref ref-type="bibr" rid="bibr23-1534735411399900">23</xref>,<xref ref-type="bibr" rid="bibr25-1534735411399900">25</xref>,<xref ref-type="bibr" rid="bibr26-1534735411399900">26</xref></sup></p>
<p>To further investigate our hypothesis, we used 17-DMAG and quercetin to co-inhibit HSP70 and HSP90 as described above. The heat treatments were then performed. The HNE1 cells were harvested for flow cytometry analysis 24 hours after heat treatment. The results showed that the heat treatment at 42°C for 2 hours in vitro only induced less than 20% of HNE1 cells apoptosis, which suggests thermotolerance of HNE1 cells. However, either quercetin or 17-DMAG alone or 17-DMAG plus quercetin significantly increased the heat-induced apoptosis of HNE1 cells. Nevertheless, the 17-DMAG plus quercetin combined with hyperthermia resulted in more intensive cytotoxicity in comparison with 17-DMAG or quercetin alone plus heat treatment (<xref ref-type="fig" rid="fig3-1534735411399900">Figure 3</xref>, <italic>P</italic> &lt; .05). Moreover, we found that the treatment of 17-DMAG plus quercetin also directly increased antitumor activity. The possible reasons may need to be further investigated.</p>
<fig id="fig3-1534735411399900" position="float">
<label>Figure 3.</label>
<caption>
<p>Co-inhibition of HSP70 and HSP90 increased HNE1 cell apoptosis induced by thermotherapy in vitro</p>
<p>Quantitative assessment of apoptotic HNE1 cells was performed by flow cytometry (mean ± <italic>SD</italic>).</p>
</caption>
<graphic xlink:href="10.1177_1534735411399900-fig3.tif"/>
</fig>
<p>In vivo, the weight of tumors from the group treated with 17-DMAG plus quercetin combined with hyperthermia showed a significant difference when compared with that of the group treated with hyperthermia alone, although the tumor-loaded mice were treated twice a week. Owing to the short period of treatment, significant differences were not found between 17-DMAG or quercetin alone plus heat treatment and heat treatment alone (<xref ref-type="fig" rid="fig4-1534735411399900">Figure 4A</xref>). Therefore, we concluded that the co-inhibition of HSP70/HSP90 showed more intensive activity in sensitizing HNE1 cells to heat treatment. To confirm this further, we detected cellular apoptosis with a TUNEL kit. The combination of co-inhibition of HSP70/HSP90 and heat treatment resulted in significantly increased tumor cell apoptosis (<xref ref-type="fig" rid="fig5-1534735411399900">Figures 5A</xref> and <xref ref-type="fig" rid="fig5-1534735411399900">5B</xref>). In addition, the treatments with 17-DMAG or quercetin alone without hyperthermia were also investigated. Both of the 2 groups showed similar tumor growth and little apoptosis with the untreated group (data not shown). Unlike the in vitro effects, the combination of 17-DMAG plus quercetin without hyperthermia did not display significant antitumor activity in vivo; this may be attributed to decreased dosage.</p>
<fig id="fig4-1534735411399900" position="float">
<label>Figure 4.</label>
<caption>
<p>Co-inhibition of HSP70 and HSP90 plus thermotherapy inhibits growth of HNE1 cell xenografts in vivo</p>
<p>The tumors were harvested and weighed after ongoing twice treatment (mean ± <italic>SD</italic>; *<italic>P</italic> &lt; .05).</p>
</caption>
<graphic xlink:href="10.1177_1534735411399900-fig4.tif"/>
</fig>
<fig id="fig5-1534735411399900" position="float">
<label>Figure 5.</label>
<caption>
<p>Co-inhibition of HSP70 and HSP90 plus thermotherapy induces more intensive apoptosis in vivo</p>
<p>A, Tumor tissues were analyzed by TUNEL assay. H represents heat, QU represents quercetin, and DM represents 17-DMAG. B, The apoptotic cells were evaluated (mean ± <italic>SD</italic>; *<italic>P</italic> &lt; .05).</p>
</caption>
<graphic xlink:href="10.1177_1534735411399900-fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-1534735411399900" sec-type="discussion">
<title>Discussion</title>
<p>Thermotherapy has been used as an effective strategy to improve the potential of the radiotherapy or chemotherapy for NPC.<sup><xref ref-type="bibr" rid="bibr18-1534735411399900">18</xref>-<xref ref-type="bibr" rid="bibr20-1534735411399900">20</xref></sup> Both the primary lesions and the most frequent metastases of neck lymph nodes are superficial, and it is thus potentially feasible to exert local heat treatment. Normally, heat stress can induce death signals that trigger programmed cell death. However, HSPs are critical components of the cancer cell’s defense mechanism against injury associated with heat stresses. Heat stress frequently results in overexpression of HSPs in cancer cells. The apoptotic program is inhibited when HSPs are elevated in cancer cells. Elevated HSP expression can also enhance tumor cell viability and impart increased resistance to subsequent chemotherapy and radiotherapy, thereby antagonizing the apoptotic effects of these treatments.<sup><xref ref-type="bibr" rid="bibr27-1534735411399900">27</xref></sup> Inhibition of HSPs can thus break down the thermotolerance of cancer cells and subsequently increase their apoptosis.<sup><xref ref-type="bibr" rid="bibr3-1534735411399900">3</xref>,<xref ref-type="bibr" rid="bibr16-1534735411399900">16</xref>,<xref ref-type="bibr" rid="bibr28-1534735411399900">28</xref></sup> Our study supports the view that the co-inhibition of HSP70/HSP90 can get more intensive sensitizer effects.</p>
<p>Thermotolerance depends on the ability of HSPs to function as molecular chaperones and prevent aggregation. Besides, HSP70 acts as a wide spectrum inhibitor of the cell death pathways in a caspase-independent way by interacting with the lysosomal membrane and preventing the activity of hydrolytic lysosomal enzymes.<sup><xref ref-type="bibr" rid="bibr29-1534735411399900">29</xref></sup> HSP90 can promote autonomous growth and leads to resistance to chemotherapy and hyperthermia.<sup><xref ref-type="bibr" rid="bibr30-1534735411399900">30</xref></sup> In this study, we first investigated the expression of the 2 important HSPs—HSP70 and HSP90—and found constructional expression of both HSP70 and HSP90 and quick upregulation of them after heat treatment in HNE1 cells. This suggests that previous or early inhibition of HSPs may be necessary and more effective. Moreover, previous studies have shown that inhibition of HSP90 induces expression of HSP70.<sup><xref ref-type="bibr" rid="bibr8-1534735411399900">8</xref>,<xref ref-type="bibr" rid="bibr31-1534735411399900">31</xref>,<xref ref-type="bibr" rid="bibr32-1534735411399900">32</xref></sup> Here, we found that inhibition of HSP70 resulted in the delayed downregulation of HSP90 in spite of not increasing the level of HSP90. The co-inhibition of HSP70 and HSP90 plus heat treatment induced significantly increased apoptosis. This suggests that the implications of not only the inhibition of HSP70 activity but also the simultaneous inhibition of HSP90 result in more extensive apoptosis after thermotherapy.</p>
<p>As known, HSPs also play important roles in the immune system as carriers of tumor antigens.<sup><xref ref-type="bibr" rid="bibr33-1534735411399900">33</xref>,<xref ref-type="bibr" rid="bibr34-1534735411399900">34</xref></sup> HSPs are able to form complexes with peptide antigens in the cytoplasm, which enhances antigen presentation in host antitumoral immunity. Especially of interest is whether HSP70 or HSP90 can help present antigens to antigen-presenting cells in different ways and thus induce antitumor immunity.<sup><xref ref-type="bibr" rid="bibr35-1534735411399900">35</xref>-<xref ref-type="bibr" rid="bibr38-1534735411399900">38</xref></sup> In the current study, the possible immune effects of co-inhibition of HSP70 and HSP90 were excluded because of the immune defaults of nude mice. Nevertheless, the antitumor effects of co-inhibition of HSP70 and HSP90 and subsequent sensitizing activity to thermotherapy are attractive for further application.</p>
<p>In the current study, quercetin and 17-DMAG were used to inhibit HSP70 and HSP90. To understand the change of HSP90 following the inhibition of HSP70, 100 µM quercetin was adopted for better inhibition in vitro. Quercetin at this concentration resulted in effective inhibition of HSP70 in vitro as described previously.<sup><xref ref-type="bibr" rid="bibr39-1534735411399900">39</xref></sup> The inhibition of HSP70 further resulted in delayed descent of HSP90. However, a lower dose of quercetin (5 mg/kg body weight, intraperitoneal) can effectively inhibit the expression of HSP70 in vivo.<sup><xref ref-type="bibr" rid="bibr22-1534735411399900">22</xref>,<xref ref-type="bibr" rid="bibr40-1534735411399900">40</xref>,<xref ref-type="bibr" rid="bibr41-1534735411399900">41</xref></sup> Therefore, the dosage of 5 mg/kg quercetin was selected for in vivo experiments. Nevertheless, the optimal dosage both of quercetin and 17-DMAG for sensitizing thermotherapy in further clinical application remains to be explored.</p>
<p>In summary, our study not only suggests that the changes of the HSP expression followed by thermotherapy are complicated and interactive but also supports the view that the co-inhibition of HSP70 and HSP90 is a preferable strategy for antagonizing activity of HSPs in tumor thermotherapy.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article:</p>
<p>This study received financial support from the Inner Mongolia Medical College Major Research Projects Funded Project (NY2006ZD009) and the Natural Science Foundation of Inner Mongolia (2009MS1107).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1534735411399900">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Georgopoulos</surname><given-names>C</given-names></name>
<name><surname>Welch</surname><given-names>WJ</given-names></name>
</person-group>. <article-title>Role of the major heat shock proteins as molecular chaperones</article-title>. <source>Annu Rev Cell Biol</source>. <year>1993</year>; <volume>9</volume>:<fpage>601</fpage>-<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr2-1534735411399900">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beere</surname><given-names>HM</given-names></name>
</person-group>. <article-title>“The stress of dying”: the role of heat shock proteins in the regulation of apoptosis</article-title>. <source>J Cell Sci</source>. <year>2004</year>;<volume>117</volume>: <fpage>2641</fpage>-<lpage>2651</lpage>.</citation>
</ref>
<ref id="bibr3-1534735411399900">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravagnan</surname><given-names>L</given-names></name>
<name><surname>Gurbuxani</surname><given-names>S</given-names></name>
<name><surname>Susin</surname><given-names>SA</given-names></name>
<name><surname>Maisse</surname><given-names>C</given-names></name>
<name><surname>Daugas</surname><given-names>E</given-names></name>
<name><surname>Zamzami</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Heat-shock protein 70 antagonizes apoptosis-inducing factor</article-title>. <source>Nat Cell Biol</source>. <year>2001</year>;<volume>3</volume>:<fpage>839</fpage>-<lpage>843</lpage>.</citation>
</ref>
<ref id="bibr4-1534735411399900">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>BH</given-names></name>
<name><surname>Plescia</surname><given-names>J</given-names></name>
<name><surname>Dohi</surname><given-names>T</given-names></name>
<name><surname>Rosa</surname><given-names>J</given-names></name>
<name><surname>Doxsey</surname><given-names>SJ</given-names></name>
<name><surname>Altieri</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network</article-title>. <source>Cell</source>. <year>2007</year>;<volume>131</volume>: <fpage>257</fpage>-<lpage>270</lpage>.</citation>
</ref>
<ref id="bibr5-1534735411399900">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gabai</surname><given-names>VL</given-names></name>
<name><surname>Meriin</surname><given-names>AB</given-names></name>
<name><surname>Yaglom</surname><given-names>JA</given-names></name>
<name><surname>Volloch</surname><given-names>VZ</given-names></name>
<name><surname>Sherman</surname><given-names>MY</given-names></name>
</person-group>. <article-title>Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging</article-title>. <source>FEBS Lett</source>. <year>1998</year>;<volume>438</volume>:<fpage>1</fpage>-<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr6-1534735411399900">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jaattela</surname><given-names>M</given-names></name>
</person-group>. <article-title>Escaping cell death: survival proteins in cancer</article-title>. <source>Exp Cell Res</source>. <year>1999</year>;<volume>248</volume>:<fpage>30</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr7-1534735411399900">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jolly</surname><given-names>C</given-names></name>
<name><surname>Morimoto</surname><given-names>RI</given-names></name>
</person-group>. <article-title>Role of the heat shock response and molecular chaperones in oncogenesis and cell death</article-title>. <source>J Natl Cancer Inst</source>. <year>2000</year>;<volume>92</volume>:<fpage>1564</fpage>-<lpage>1572</lpage>.</citation>
</ref>
<ref id="bibr8-1534735411399900">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Drysdale</surname><given-names>MJ</given-names></name>
<name><surname>Brough</surname><given-names>PA</given-names></name>
<name><surname>Massey</surname><given-names>A</given-names></name>
<name><surname>Jensen</surname><given-names>MR</given-names></name>
<name><surname>Schoepfer</surname><given-names>J</given-names></name>
</person-group>. <article-title>Targeting Hsp90 for the treatment of cancer</article-title>. <source>Curr Opin Drug Discov Devel</source>. <year>2006</year>;<volume>9</volume>:<fpage>483</fpage>-<lpage>495</lpage>.</citation>
</ref>
<ref id="bibr9-1534735411399900">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Isomoto</surname><given-names>H</given-names></name>
<name><surname>Oka</surname><given-names>M</given-names></name>
<name><surname>Yano</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer</article-title>. <source>Cancer Lett</source>. <year>2003</year>;<volume>198</volume>:<fpage>219</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr10-1534735411399900">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Q</given-names></name>
<name><surname>Hu</surname><given-names>JK</given-names></name>
<name><surname>Lohr</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Heat-induced gene expression as a novel targeted cancer gene therapy strategy</article-title>. <source>Cancer Res</source>. <year>2000</year>;<volume>60</volume>:<fpage>3435</fpage>-<lpage>3439</lpage>.</citation>
</ref>
<ref id="bibr11-1534735411399900">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garrido</surname><given-names>C</given-names></name>
<name><surname>Brunet</surname><given-names>M</given-names></name>
<name><surname>Didelot</surname><given-names>C</given-names></name>
<name><surname>Zermati</surname><given-names>Y</given-names></name>
<name><surname>Schmitt</surname><given-names>E</given-names></name>
<name><surname>Kroemer</surname><given-names>G</given-names></name>
</person-group>. <article-title>Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties</article-title>. <source>Cell Cycle</source>. <year>2006</year>;<volume>5</volume>: <fpage>2592</fpage>-<lpage>2601</lpage>.</citation>
</ref>
<ref id="bibr12-1534735411399900">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zaarur</surname><given-names>N</given-names></name>
<name><surname>Gabai</surname><given-names>VL</given-names></name>
<name><surname>Porco</surname><given-names>JA</given-names><suffix>Jr</suffix></name>
<name><surname>Calderwood</surname><given-names>S</given-names></name>
<name><surname>Sherman</surname><given-names>MY</given-names></name>
</person-group>. <article-title>Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors</article-title>. <source>Cancer Res</source>. <year>2006</year>;<volume>66</volume>: <fpage>1783</fpage>-<lpage>1791</lpage>.</citation>
</ref>
<ref id="bibr13-1534735411399900">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calderwood</surname><given-names>SK</given-names></name>
<name><surname>Asea</surname><given-names>A</given-names></name>
</person-group>. <article-title>Targeting HSP70-induced thermotolerance for design of thermal sensitizers</article-title>. <source>Int J Hyperthermia</source>. <year>2002</year>;<volume>18</volume>:<fpage>597</fpage>-<lpage>608</lpage>.</citation>
</ref>
<ref id="bibr14-1534735411399900">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huston</surname><given-names>A</given-names></name>
<name><surname>Leleu</surname><given-names>X</given-names></name>
<name><surname>Jia</surname><given-names>X</given-names></name><etal/>
</person-group>. <article-title>Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment</article-title>. <source>Clin Cancer Res</source>. <year>2008</year>;<volume>14</volume>:<fpage>865</fpage>-<lpage>874</lpage>.</citation>
</ref>
<ref id="bibr15-1534735411399900">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>A</given-names></name>
<name><surname>Ciafrè</surname><given-names>S</given-names></name>
<name><surname>Balsamo</surname><given-names>M</given-names></name>
<name><surname>Pierimarchi</surname><given-names>P</given-names></name>
<name><surname>Santoro</surname><given-names>MG</given-names></name>
</person-group>. <article-title>Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer</article-title>. <source>Cancer Res</source>. <year>2006</year>;<volume>66</volume>:<fpage>7678</fpage>-<lpage>7685</lpage>.</citation>
</ref>
<ref id="bibr16-1534735411399900">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Workman</surname><given-names>P</given-names></name>
<name><surname>de Billy</surname><given-names>E</given-names></name>
</person-group>. <article-title>Putting the heat on cancer</article-title>. <source>Nat Med</source>. <year>2007</year>;<volume>13</volume>:<fpage>1415</fpage>-<lpage>1417</lpage>.</citation>
</ref>
<ref id="bibr17-1534735411399900">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baujat</surname><given-names>B</given-names></name>
<name><surname>Audry</surname><given-names>H</given-names></name>
<name><surname>Bourhis</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2006</year>;<volume>64</volume>:<fpage>47</fpage>-<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr18-1534735411399900">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>QR</given-names></name>
<name><surname>Chou</surname><given-names>CK</given-names></name>
<name><surname>McDougall</surname><given-names>JA</given-names></name>
<name><surname>Chan</surname><given-names>KW</given-names></name>
<name><surname>Luk</surname><given-names>KH</given-names></name>
</person-group>. <article-title>Intracavitary hyperthermia applicators for treating nasopharyngeal and cervical cancers</article-title>. <source>Int J Hyperthermia</source>. <year>1990</year>;<volume>6</volume>: <fpage>997</fpage>-<lpage>1004</lpage>.</citation>
</ref>
<ref id="bibr19-1534735411399900">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>YR</given-names></name>
<name><surname>Zheng</surname><given-names>L</given-names></name>
<name><surname>Yang</surname><given-names>CL</given-names></name>
<name><surname>Wei</surname><given-names>D</given-names></name>
<name><surname>Sun</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Prognostic value of changes of peripheral blood T cell subsets after thermoradiotherapy for nasopharyngeal carcinoma [in Chinese]</article-title>. <source>Di Yi Jun Yi Da Xue Xue Bao</source>. <year>2004</year>;<volume>24</volume>:<fpage>818</fpage>-<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr20-1534735411399900">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ha</surname><given-names>DK</given-names></name>
<name><surname>Lau</surname><given-names>WH</given-names></name>
</person-group>. <article-title>Effect of anticancer drugs and hyperthermia on nasopharyngeal carcinoma cell line in vitro</article-title>. <source>Cancer Lett</source>. <year>1989</year>;<volume>45</volume>:<fpage>103</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr21-1534735411399900">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hollingshead</surname><given-names>M</given-names></name>
<name><surname>Alley</surname><given-names>M</given-names></name>
<name><surname>Burger</surname><given-names>AM</given-names></name><etal/>
</person-group>. <article-title>In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17- demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative</article-title>. <source>Cancer Chemother Pharmacol</source>. <year>2005</year>; <volume>56</volume>:<fpage>115</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr22-1534735411399900">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schlachterman</surname><given-names>A</given-names></name>
<name><surname>Valle</surname><given-names>F</given-names></name>
<name><surname>Wall</surname><given-names>KM</given-names></name><etal/>
</person-group>. <article-title>Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model</article-title>. <source>Transl Oncol</source>. <year>2008</year>;<volume>1</volume>: <fpage>19</fpage>-<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr23-1534735411399900">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wei</surname><given-names>YQ</given-names></name>
<name><surname>Zhao</surname><given-names>X</given-names></name>
<name><surname>Kariya</surname><given-names>Y</given-names></name>
<name><surname>Fukata</surname><given-names>H</given-names></name>
<name><surname>Teshigawara</surname><given-names>K</given-names></name>
<name><surname>Uchida</surname><given-names>A</given-names></name>
</person-group>. <article-title>Induction of apoptosis by quercetin: involvement of heat shock protein</article-title>. <source>Cancer Res</source>. <year>1994</year>;<volume>54</volume>:<fpage>4952</fpage>-<lpage>4957</lpage>.</citation>
</ref>
<ref id="bibr24-1534735411399900">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaikwad</surname><given-names>A</given-names></name>
<name><surname>Poblenz</surname><given-names>A</given-names></name>
<name><surname>Haridas</surname><given-names>V</given-names></name>
<name><surname>Zhang</surname><given-names>C</given-names></name>
<name><surname>Duvic</surname><given-names>M</given-names></name>
<name><surname>Gutterman</surname><given-names>J</given-names></name>
</person-group>. <article-title>Triterpenoid electrophiles (avicins) suppress heat shock protein-70 and x-linked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: implications for proapoptotic activity</article-title>. <source>Clin Cancer Res</source>. <year>2005</year>; <volume>11</volume>:<fpage>1953</fpage>-<lpage>1962</lpage>.</citation>
</ref>
<ref id="bibr25-1534735411399900">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wachsberger</surname><given-names>PR</given-names></name>
<name><surname>Burd</surname><given-names>R</given-names></name>
<name><surname>Bhala</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia</article-title>. <source>Int J Hyperthermia</source>. <year>2003</year>;<volume>19</volume>:<fpage>507</fpage>-<lpage>519</lpage>.</citation>
</ref>
<ref id="bibr26-1534735411399900">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aghdassi</surname><given-names>A</given-names></name>
<name><surname>Phillips</surname><given-names>P</given-names></name>
<name><surname>Dudeja</surname><given-names>V</given-names></name><etal/>
</person-group>. <article-title>Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma</article-title>. <source>Cancer Res</source>. <year>2007</year>;<volume>67</volume>:<fpage>616</fpage>-<lpage>625</lpage>.</citation>
</ref>
<ref id="bibr27-1534735411399900">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rylander</surname><given-names>MN</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
<name><surname>Bass</surname><given-names>J</given-names></name>
<name><surname>Diller</surname><given-names>KR</given-names></name>
</person-group>. <article-title>Thermally induced injury and heat-shock protein expression in cells and tissues</article-title>. <source>Ann NY Acad Sci</source>. <year>2005</year>;<volume>1066</volume>:<fpage>222</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr28-1534735411399900">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vastag</surname><given-names>B</given-names></name>
</person-group>. <article-title>HSP-90 inhibitors promise to complement cancer therapies</article-title>. <source>Nat Biotechnol</source>. <year>2006</year>;<volume>24</volume>:<year>1307</year>.</citation>
</ref>
<ref id="bibr29-1534735411399900">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daugaard</surname><given-names>M</given-names></name>
<name><surname>Rohde</surname><given-names>M</given-names></name>
<name><surname>Jaattela</surname><given-names>M</given-names></name>
</person-group>. <article-title>The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions</article-title>. <source>FEBS Lett</source>. <year>2007</year>;<volume>581</volume>:<fpage>3702</fpage>-<lpage>3710</lpage>.</citation>
</ref>
<ref id="bibr30-1534735411399900">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calderwood</surname><given-names>SK</given-names></name>
<name><surname>Ciocca</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Heat shock proteins: stress proteins with Janus-like properties in cancer</article-title>. <source>Int J Hyperthermia</source>. <year>2008</year>;<volume>24</volume>:<fpage>31</fpage>-<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr31-1534735411399900">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dakappagari</surname><given-names>N</given-names></name>
<name><surname>Neely</surname><given-names>L</given-names></name>
<name><surname>Tangri</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors</article-title>. <source>Biomarkers</source>. <year>2010</year>;<volume>15</volume>:<fpage>31</fpage>-<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr32-1534735411399900">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Powers</surname><given-names>MV</given-names></name>
<name><surname>Clarke</surname><given-names>PA</given-names></name>
<name><surname>Workman</surname><given-names>P</given-names></name>
</person-group>. <article-title>Death by chaperone: HSP90, HSP70 or both?</article-title> <source>Cell Cycle</source>. <year>2009</year>;<volume>8</volume>:<fpage>518</fpage>-<lpage>526</lpage>.</citation>
</ref>
<ref id="bibr33-1534735411399900">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calderwood</surname><given-names>SK</given-names></name>
<name><surname>Theriault</surname><given-names>JR</given-names></name>
<name><surname>Gong</surname><given-names>J</given-names></name>
</person-group>. <article-title>How is the immune response affected by hyperthermia and heat shock proteins?</article-title> <source>Int J Hyperthermia</source>. <year>2005</year>;<volume>21</volume>:<fpage>713</fpage>-<lpage>716</lpage>.</citation>
</ref>
<ref id="bibr34-1534735411399900">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Srivastava</surname><given-names>PK</given-names></name>
</person-group>. <article-title>Immunotherapy for human cancer using heat shock protein-peptide complexes</article-title>. <source>Curr Oncol Rep</source>. <year>2005</year>;<volume>7</volume>: <fpage>104</fpage>-<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr35-1534735411399900">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ren</surname><given-names>W</given-names></name>
<name><surname>Strube</surname><given-names>R</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>SY</given-names></name>
<name><surname>Huang</surname><given-names>XF</given-names></name>
</person-group>. <article-title>Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine</article-title>. <source>Cancer Res</source>. <year>2004</year>; <volume>64</volume>:<fpage>6645</fpage>-<lpage>6651</lpage>.</citation>
</ref>
<ref id="bibr36-1534735411399900">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ito</surname><given-names>A</given-names></name>
<name><surname>Shinkai</surname><given-names>M</given-names></name>
<name><surname>Honda</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles</article-title>. <source>Cancer Immunol Immunother</source>. <year>2003</year>;<volume>52</volume>:<fpage>80</fpage>-<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr37-1534735411399900">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Enomoto</surname><given-names>Y</given-names></name>
<name><surname>Bharti</surname><given-names>A</given-names></name>
<name><surname>Khaleque</surname><given-names>AA</given-names></name><etal/>
</person-group>. <article-title>Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells</article-title>. <source>J Immunol</source>. <year>2006</year>;<volume>177</volume>:<fpage>5946</fpage>-<lpage>5955</lpage>.</citation>
</ref>
<ref id="bibr38-1534735411399900">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurotaki</surname><given-names>T</given-names></name>
<name><surname>Tamura</surname><given-names>Y</given-names></name>
<name><surname>Ueda</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway</article-title>. <source>J Immunol</source>. <year>2007</year>; <volume>179</volume>:<fpage>1803</fpage>-<lpage>1813</lpage>.</citation>
</ref>
<ref id="bibr39-1534735411399900">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>DP</given-names></name>
<name><surname>Li Calzi</surname><given-names>S</given-names></name>
<name><surname>Sánchez</surname><given-names>ER</given-names></name>
</person-group>. <article-title>Inhibition of heat shock factor activity prevents heat shock potentiation of glucocorticoid receptor-mediated gene expression</article-title>. <source>Cell Stress Chaperones</source>. <year>1999</year>;<volume>4</volume>:<fpage>223</fpage>-<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr40-1534735411399900">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malyshev</surname><given-names>I</given-names></name>
<name><surname>Bayda</surname><given-names>LA</given-names></name>
<name><surname>Trifonov</surname><given-names>AI</given-names></name><etal/>
</person-group>. <article-title>Cross-talk between nitric oxide and HSP70 in the antihypotensive effect of adaptation to heat</article-title>. <source>Physiol Res</source>. <year>2000</year>;<volume>49</volume>:<fpage>99</fpage>-<lpage>105</lpage>.</citation>
</ref>
<ref id="bibr41-1534735411399900">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>ZQ</given-names></name>
<name><surname>Peng</surname><given-names>YZ</given-names></name>
<name><surname>Li</surname><given-names>XL</given-names></name>
<name><surname>Huang</surname><given-names>YS</given-names></name>
<name><surname>Yang</surname><given-names>ZC</given-names></name>
</person-group>. <article-title>Induction of heat shock protein 70 by sodium arsenite attenuates burn-induced intestinal injury in severe burned rats</article-title>. <source>Burns</source>. <year>2008</year>;<volume>34</volume>:<fpage>247</fpage>-<lpage>253</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>